{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:50Z","timestamp":1792788650985,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The University of Illinois at Chicago","id":[{"id":"https:\/\/ror.org\/02mpq6x41","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.wneu.2020.08.161","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T12:34:54Z","timestamp":1599050094000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Cerebral Microdialysis as a Tool for Assessing the Delivery of Chemotherapy in Brain Tumor Patients"],"prefix":"10.1016","volume":"145","author":[{"given":"Charles F.","family":"Pierce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Kwasnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajani S.","family":"Lakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4993-9265","authenticated-orcid":false,"given":"Herbert H.","family":"Engelhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2020.08.161_bib1","series-title":"Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy","first-page":"113","article-title":"Biology of the blood-brain and blood-brain tumor barriers","author":"Engelhard","year":"2018"},{"key":"10.1016\/j.wneu.2020.08.161_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood\u2013brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.wneu.2020.08.161_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12987-017-0088-8","article-title":"The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma","volume":"15","author":"Jackson","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.wneu.2020.08.161_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11060-014-1415-4","article-title":"A\u00a0pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent","volume":"118","author":"Portnow","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.08.161_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11060-008-9678-2","article-title":"Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study","volume":"91","author":"Blakeley","year":"2009","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.08.161_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0269881116645269","article-title":"True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence","volume":"30","author":"Goetghebeur","year":"2016","journal-title":"J\u00a0Psychopharmacol Oxf Engl"},{"key":"10.1016\/j.wneu.2020.08.161_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/neuros\/nyy392","article-title":"Cytokine microdialysis for real-time immune monitoring in glioblastoma patients undergoing checkpoint blockade","volume":"84","author":"Lynes","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2020.08.161_bib8","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/AAC.02570-12","article-title":"Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury","volume":"57","author":"Dahyot-Fizelier","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.wneu.2020.08.161_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijantimicag.2011.11.019","article-title":"Penetration of doripenem in human brain: an observational microdialysis study in patients with acute brain injury","volume":"39","author":"Poeppl","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.wneu.2020.08.161_bib10","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1016\/j.wneu.2019.09.099","article-title":"Mild hyperventilation in traumatic brain injury\u2014relation to cerebral energy metabolism, pressure autoregulation, and clinical outcome","volume":"133","author":"Svedung Wettervik","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2020.08.161_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejpb.2019.04.004","article-title":"Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: how can the formulation make a difference?","volume":"139","author":"Hu","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.wneu.2020.08.161_bib12","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.xphs.2017.03.009","article-title":"The impact of liposomal formulations on the release and brain delivery of methotrexate: an in\u00a0vivo microdialysis study","volume":"106","author":"Hu","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.wneu.2020.08.161_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jpba.2017.11.047","article-title":"Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-induced blood-brain barrier disruption as determined by microdialysis","volume":"149","author":"Lin","year":"2018","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.wneu.2020.08.161_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuroimage.2017.04.068","article-title":"Combined PET and microdialysis for in\u00a0vivo estimation of drug blood-brain barrier transport and brain unbound concentrations","volume":"155","author":"Gustafsson","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.wneu.2020.08.161_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003088-200241100-00001","article-title":"Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain","volume":"41","author":"de Lange","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.wneu.2020.08.161_bib16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1208\/s12248-017-0050-3","article-title":"Microdialysis: the key to physiologically based model prediction of human CNS target site concentrations","volume":"19","author":"Yamamoto","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.wneu.2020.08.161_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00280-018-3705-6","article-title":"Plasma and brain pharmacokinetics of letrozole and drug interaction studies with temozolomide in NOD-scid gamma mice and Sprague Dawley rats","volume":"83","author":"Arora","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2020.08.161_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/bj0690099","article-title":"A\u00a0microdialysis procedure for extraction and isolation of corticosteroids from peripheral blood plasma","volume":"69","author":"Kalant","year":"1958","journal-title":"Biochem J"},{"key":"10.1016\/j.wneu.2020.08.161_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/ALN.0b013e318194b620","article-title":"Glutamate, microdialysis, and cerebral ischemia: lost in translation?","volume":"110","author":"Benveniste","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.wneu.2020.08.161_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1471-4159.1986.tb02847.x","article-title":"Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in\u00a0vivo dialysis of the rat hippocampus","volume":"47","author":"Sandberg","year":"1986","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.wneu.2020.08.161_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11910-018-0915-6","article-title":"Cerebral microdialysis in neurocritical care","volume":"18","author":"Zhou","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.wneu.2020.08.161_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00701-008-0021-7","article-title":"Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study","volume":"150","author":"Mazzeo","year":"2008","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2020.08.161_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF01401106","article-title":"Treatment of malignant glioma by a new therapeutic principle","volume":"114","author":"Ronquist","year":"1992","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2020.08.161_bib24","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","article-title":"The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation","volume":"15","author":"Portnow","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00280-013-2172-3","article-title":"Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model","volume":"72","author":"Grossman","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2020.08.161_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/dmd.113.055228","article-title":"The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain","volume":"42","author":"Sane","year":"2014","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1016\/j.wneu.2020.08.161_bib27","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1158\/1078-0432.CCR-16-1518","article-title":"Neural stem cell-based anticancer gene therapy: a first-in-human study in recurrent high-grade glioma patients","volume":"23","author":"Portnow","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00280-012-1867-1","article-title":"The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas","volume":"70","author":"Grossman","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2020.08.161_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-009-9990-5","article-title":"In\u00a0vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines","volume":"97","author":"Marcus","year":"2010","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.08.161_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneumeth.2017.08.013","article-title":"Microdialysis and its use in behavioural studies: focus on acetylcholine","volume":"300","author":"K\u00f6nig","year":"2018","journal-title":"J\u00a0Neurosci Methods"},{"key":"10.1016\/j.wneu.2020.08.161_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00280-019-03864-9","article-title":"CNS penetration of the CDK4\/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors","volume":"84","author":"Patel","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2020.08.161_bib32","doi-asserted-by":"crossref","first-page":"105106","DOI":"10.1016\/j.ejps.2019.105106","article-title":"CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model","volume":"142","author":"Campagne","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.wneu.2020.08.161_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11064-010-0276-2","article-title":"Acute depression of energy metabolism after microdialysis probe implantation is distinct from ischemia-induced changes in mouse brain","volume":"36","author":"Sumbria","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib34","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1021\/pr901088r","article-title":"Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study","volume":"9","author":"Wibom","year":"2010","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpba.2018.08.043","article-title":"Sensitive targeted methods for brain metabolomic studies in microdialysis samples","volume":"161","author":"Bongaerts","year":"2018","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.wneu.2020.08.161_bib36","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1007\/s12035-016-9929-8","article-title":"A\u00a0review on microdialysis calibration methods: the theory and current related efforts","volume":"54","author":"Kho","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.wneu.2020.08.161_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00280-013-2205-y","article-title":"The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis","volume":"72","author":"Dave","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2020.08.161_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/dmd.115.068445","article-title":"Simvastatin hydroxy acid fails to attain sufficient central nervous system tumor exposure to achieve a cytotoxic effect: results of a preclinical cerebral microdialysis study","volume":"44","author":"Patel","year":"2016","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1016\/j.wneu.2020.08.161_bib39","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1002\/jps.22723","article-title":"Magnetic resonance imaging-guided microdialysis cannula implantation in a spontaneous high-grade glioma murine model","volume":"100","author":"Elmeliegy","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.wneu.2020.08.161_bib40","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1023\/A:1016239822287","article-title":"The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain","volume":"12","author":"de Lange","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib41","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1208\/s12248-017-0108-2","article-title":"Microdialysis as an important technique in systems pharmacology\u2014a historical and methodological review","volume":"19","author":"Hammarlund-Udenaes","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.wneu.2020.08.161_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-015-1875-1","article-title":"Current status of intratumoral therapy for glioblastoma","volume":"125","author":"Mehta","year":"2015","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.08.161_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12987-016-0040-3","article-title":"Fluid and ion transfer across the blood\u2013brain and blood\u2013cerebrospinal fluid barriers; a comparative account of mechanisms and roles","volume":"13","author":"Hladky","year":"2016","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.wneu.2020.08.161_bib44","series-title":"Handbook of Brain Tumor Chemotherapy","article-title":"Biology of the blood-brain and \u201cblood-brain tumor\u201d barriers","author":"Engelhard","year":"2005"},{"key":"10.1016\/j.wneu.2020.08.161_bib45","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/jps.10424","article-title":"Blood-brain barrier efflux transport","volume":"92","author":"Golden","year":"2003","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.wneu.2020.08.161_bib46","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00280-015-2713-z","article-title":"Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study","volume":"75","author":"Patel","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2020.08.161_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00280-007-0464-1","article-title":"Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in\u00a0vivo assessment in rats employing intracerebral microdialysis","volume":"61","author":"Apparaju","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2020.08.161_bib48","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/acs.molpharmaceut.6b00031","article-title":"Integrating in silico and in\u00a0vitro approaches to predict drug accessibility to the central nervous system","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.wneu.2020.08.161_bib49","doi-asserted-by":"crossref","first-page":"E967","DOI":"10.1093\/neuros\/nyz218","article-title":"Phase 0 clinical trial strategies for the neurosurgical oncologist","volume":"85","author":"Sanai","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2020.08.161_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/dmd.110.035998","article-title":"Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods","volume":"39","author":"Frid\u00e9n","year":"2011","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1016\/j.wneu.2020.08.161_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/nnm-2019-0169","article-title":"Nanoparticle brain delivery: a guide to verification methods","volume":"15","author":"Yokel","year":"2020","journal-title":"Nanomed"},{"key":"10.1016\/j.wneu.2020.08.161_bib52","first-page":"355","article-title":"Model for concomitant microdialysis sampling of the pons and cerebral cortex in rhesus macaques (Macaca mulatta)","volume":"63","author":"McCully","year":"2013","journal-title":"Comp Med"},{"key":"10.1016\/j.wneu.2020.08.161_bib53","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","article-title":"Tumor development and angiogenesis in adult brain tumor: glioblastoma","volume":"57","author":"Ahir","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.wneu.2020.08.161_bib54","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1002\/cncr.30965","article-title":"Diagnosis and management of primary central nervous system lymphoma: primary CNS lymphoma","volume":"123","author":"Han","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2020.08.161_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I","article-title":"The clinical pharmacology of methotrexate: new applications of an old drug","volume":"41","author":"Bleyer","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2020.08.161_bib56","first-page":"3835","article-title":"Cytokinetic and cytotoxic effects of antimetabolites on 9L rat brain tumor cells in\u00a0vitro","volume":"41","author":"Weizsaecker","year":"1981","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib57","first-page":"1983","article-title":"Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470","volume":"56","author":"Devineni","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib58","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1023\/A:1018945529611","article-title":"Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats","volume":"16","author":"Dukic","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib59","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3390\/ijms20071562","article-title":"Are there thresholds in glioblastoma cell death responses triggered by temozolomide?","volume":"20","author":"He","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2020.08.161_bib60","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/jpet.102.048587","article-title":"Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models","volume":"305","author":"Ma","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.wneu.2020.08.161_bib61","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1208\/aapsj070366","article-title":"In\u00a0vivo microdialysis for PK and PD studies of anticancer drugs","volume":"7","author":"Zhou","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.wneu.2020.08.161_bib62","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-07-0658","article-title":"Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain disposition","volume":"13","author":"Zhou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib63","first-page":"5491","article-title":"Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470","volume":"61","author":"Ma","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2020.08.161_bib64","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bit.260110607","article-title":"Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius","volume":"11","author":"Arcamone","year":"1969","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.wneu.2020.08.161_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejps.2013.11.010","article-title":"Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data","volume":"57","author":"Jacus","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.wneu.2020.08.161_bib66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41416-019-0652-x","article-title":"Metabolic response patterns in brain microdialysis fluids and serum during interstitial cisplatin treatment of high-grade glioma","volume":"122","author":"Bj\u00f6rkblom","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.wneu.2020.08.161_bib67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11060-006-9186-1","article-title":"Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB)","volume":"80","author":"Bergenheim","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.wneu.2020.08.161_bib68","first-page":"1634","article-title":"A\u00a0neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl\/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas","volume":"49","author":"Portnow","year":"2013","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.wneu.2020.08.161_bib69","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1021\/acs.analchem.5b03541","article-title":"Microfabrication and in\u00a0vivo performance of a microdialysis probe with embedded membrane","volume":"88","author":"Lee","year":"2016","journal-title":"Anal Chem"},{"key":"10.1016\/j.wneu.2020.08.161_bib70","series-title":"Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics and Immunotherapy","first-page":"229","article-title":"Nanoparticles as therapeutic agents for patients with brain tumors","author":"Lee","year":"2018"},{"key":"10.1016\/j.wneu.2020.08.161_bib71","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2741\/4368","article-title":"Lactic dehydrogenase and cancer: an overview","volume":"20","author":"Naviglio","year":"2015","journal-title":"Front Biosci"},{"key":"10.1016\/j.wneu.2020.08.161_bib72","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1007\/s00216-017-0447-y","article-title":"Heparin-gold nanoparticles for enhanced microdialysis sampling","volume":"409","author":"Giorgi-Coll","year":"2017","journal-title":"Anal Bioanal Chem"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020319306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020319306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:51:03Z","timestamp":1761814263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875020319306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":72,"alternative-id":["S1878875020319306"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2020.08.161","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral Microdialysis as a Tool for Assessing the Delivery of Chemotherapy in Brain Tumor Patients","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2020.08.161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}